CANBRIDGE-B

1228
1.6701.76% ( -0.030 )
Delay Closed: Nov 16, 16:08:00

Overview

CANBRIDGE-B (1228)

CANbridge Pharmaceuticals Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and onco...

Open
1.620
High
1.795
Low
1.595
Prev. Close
1.700
Volume
143.59K
Turnover
235.25K
Avg Price
1.638
Bid/Ask Ratio
-20.00%
Amplitude
11.76%
52wk High
3.500
Volume Ratio
0.04
Turnover Ratio
0.02%
52wk Low
1.595
HK Mkt Cap
998.20M
Market CapHKD
998.20M
P/ETTM
Loss
P/EDynamic
Loss
P/EStatic
--
EPSTTM
-0.157
EPSDynamic
-0.143
EPSStatic
--
BVPS
-0.38
P/B
--
HK Shares
597.72M
Dividend YieldTTM
--
DividendTTM
--
Shares
597.72M
Min lot size
1,000
Currency
HKD

CANBRIDGE-B Analyst Rating

View more

Forecast & Rating

May 23, 2024
Price forecast
HK$12.30636.53%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Jul, 3

    CANbridge closed at HK$1.980 on the day, down 1.0% after dipping to an intraday low of HK$1.900 in the afternoon session, primarily driven by news flow surrounding its 2026 Annual General Meeting where all resolutions were approved, and the ongoing story of a turnaround to profitability in fiscal 2025. For Q4 2025, EPS came in at -HK$0.0517 with a YoY loss narrowing of 78.85%, and net profit of -HK$24.7 million improved 76.23% YoY, despite a 28.08% revenue decline to HK$15.4 million, indicating cost control as the driver. At HK$1.98, the stock remains 43.43% below its 52-week high of HK$3.50 and 695.18% above its low of HK$0.249, while trading under both the 20-day (HK$2.008) and 60-day (HK$2.187) moving averages. However, recent discounted share placements (e.g., ~19.86% discount to raise ~HK$22.1 million) continue to dilute equity.

  2. Jul, 2

    北海康成今日单边下行,上午盘从 2.29 港元低开并持续走低,下午盘跌势未止,最低触及 2.01 港元,最终收跌 25.56%,报 2.01 港元,全天成交 86.3 万股,换手率仅 0.14%。今日大跌主因是昨日公司召开 2026 年股东大会并批准所有决议后,市场情绪转淡。财报方面,Q4 2025 净亏损收窄 76.23% 至 2469.82 万港元,EPS 同比改善 78.85% 至-0.0517 港元,营业利润仍为负,亏损幅度同比收窄 56.85%。当前股价已跌破 20 日均线及 60 日均线,距 52 周高点 3.5 港元跌去 42.57%,但 YTD 仍为-14.83%,年初至今表现偏弱。尽管基本面亏损持续收窄,但今非昔比的成交量暗示投资者缺乏跟进意愿。

News

Bullish vs. Bearish — Last 3 Months

1.4k followers · 0 opinions
▲Bullish50%
50%Bearish▼